Clinical Trials Browser

Phase EARLY_PHASE1 × NETWORK × 1 year × Clear all

NCT04161248 2026-02-02

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, B-Cell

NCT06520449 2025-09-25

NTA-476

Phase EARLY_PHASE1 Completed

Prostatic Neoplasms

NCT04139304 2025-06-29

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Phase EARLY_PHASE1 Recruiting

Plasmablastic Lymphoma